Michelle F. Magee, MD; MedStar Health and Georgetown University School of Medicine
Michelle F. Magee, MD, is an endocrinologist at MedStar Washington Hospital Center (MWHC), a principal investigator at MedStar Health Research Institute (MHRI), and an associate professor of Medicine at Georgetown University School of Medicine, Washington, DC.
At MedStar, Dr. Magee serves as director of the MedStar Diabetes Institute (MDI). In this capacity she leads and supports diabetes clinical, educational and research programs. These programs include diabetes ambulatory care, hospital glycemic management services and research across MedStar Health, and diabetes education in the community. Dr. Magee's work focuses on high risk, minority, and underserved populations with or at risk for diabetes.
Dr. Magee is currently leading a MedStar Health initiative to provide survival skills self-care education and intensive medication management to adults with uncontrolled type 2 diabetes through an evidence-based 12-week boot-camp program. She also is leading the NIH-funded Diabetes to Go study, an innovative technology-assisted program created to provide inpatient diabetes self-care education and care transition planning at hospital discharge for patients with diabetes.
In addition, Dr. Magee has participated as an investigator on more than 50 clinical studies, including the landmark NIH Diabetes Prevention Program (DPP) and Women's Health Initiative studies. She has served as a co-principal investigator for the NIH “Bypass Angioplasty Revascularization Investigation Type 2 Diabetes Study” at MWHC and for “Changing the Healthcare Delivery Model: A Community Health Worker/Mobile Chronic Care Team Strategy,” funded by the Patient-Centered Outcomes Research Institute and conducted in collaboration with George Washington and Howard Universities.
Under Dr. Magee's leadership, MDI delivers blood pressure screenings in DC community barber shops and Lifestyle Balance diabetes prevention programs, which have collectively provided free health education services to almost 4,000 DC residents at risk for cardiovascular disease (CVD) and/or diabetes.
At the national level, Dr. Magee has served or serves the American Diabetes Association (ADA), the American Heart Association (The Guideline Advantage), the Society of Hospital Medicine, the Endocrine Society, and the American Association of Diabetes Educators. Dr. Magee has received an ADA Promising Practice Award of Excellence and a Microsoft Health Users Award for her innovative work on web-based personal health records. She has been listed as a “Super Doctor” in the DC-Baltimore-Northern Virginia area for 3 years in a row.
Her medical degree is from the Royal College of Surgeons in Ireland. She completed a residency in internal medicine and a fellowship in endocrinology and metabolism at George Washington University.